📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Cocrystal Pharma

1.1 - Company Overview

Cocrystal Pharma Logo

Cocrystal Pharma

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of antiviral therapeutics and candidates, including oral and inhaled PB2 inhibitor CC-42344 for Influenza A (oral: Phase 1 completed, Phase 2 ongoing; inhaled: Phase 1 and 2 completed); preclinical replication inhibitors for Influenza A/B; oral pan-viral protease inhibitor CDI-988 targeting coronavirus and norovirus (preclinical completed, Phase 1 ongoing); and discovery/preclinical pan-viral and norovirus replication inhibitors.

Products and services

  • CDI-988 Oral Pan-viral Protease Inhibitor: Dual-action oral protease inhibitor targeting both coronavirus and norovirus
  • Completed preclinical studies with Phase 1 ongoing to advance pan-viral antiviral activity
  • Oral PB2 Inhibitor CC-42344 for Influenza A: Clinical-stage oral PB2 inhibitor engineered to target pandemic and seasonal influenza A, including resistant strains
  • Completed Phase 1 with Phase 2 ongoing
  • Inhaled PB2 Inhibitor CC-42344 for Influenza A: Inhaled-formulation PB2 inhibitor architected to directly target influenza-infected respiratory cells, with completed Phase 1 and Phase 2 clinical studies.

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Cocrystal Pharma

Arpida Logo

Arpida

HQ: Switzerland Website
  • Description: Provider of biopharmaceutical discovery and development of novel products for the treatment of bacterial infections.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Arpida company profile →
Pherecydes Pharma Logo

Pherecydes Pharma

HQ: France Website
  • Description: Provider of innovative biotechnology focused on developing personalized phage therapy to treat bacterial infections. The company develops bacteriophages against infections and has launched a multicenter European phage therapy trial to evaluate treatment on infected burn wounds.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pherecydes Pharma company profile →
Cempra Logo

Cempra

HQ: United States Website
  • Description: Provider of medicines for the treatment of bacterial infections and chronic illnesses.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cempra company profile →
HandyLab Logo

HandyLab

HQ: United States Website
  • Description: Provider of medical technology developing and manufacturing molecular diagnostic assays and automation platforms. Using patented real-time microfluidic PCR technology, its proprietary platform reduces the time, cost, and complexity of testing while improving result quality, and is positioned to decentralize.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full HandyLab company profile →
Scynexis Logo

Scynexis

HQ: United States Website
  • Description: Provider of drug discovery, development and manufacturing projects focused on antifungal therapeutics, including ibrexafungerp, a novel oral/IV glucan synthase inhibitor for serious and resistant fungal infections; SCY-247, a second-generation broad-spectrum triterpenoid; VVC and RVVC treatments; and the MARIO study evaluating oral step-down after IV echinocandin for invasive candidiasis and candidemia.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Scynexis company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Cocrystal Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Cocrystal Pharma

2.2 - Growth funds investing in similar companies to Cocrystal Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Cocrystal Pharma

4.2 - Public trading comparable groups for Cocrystal Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Cocrystal Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Cocrystal Pharma

What does Cocrystal Pharma do?

Cocrystal Pharma is a provider of antiviral therapeutics and candidates, including oral and inhaled PB2 inhibitor CC-42344 for Influenza A (oral: Phase 1 completed, Phase 2 ongoing; inhaled: Phase 1 and 2 completed); preclinical replication inhibitors for Influenza A/B; oral pan-viral protease inhibitor CDI-988 targeting coronavirus and norovirus (preclinical completed, Phase 1 ongoing); and discovery/preclinical pan-viral and norovirus replication inhibitors.

Who are Cocrystal Pharma's competitors?

Cocrystal Pharma's competitors and similar companies include Arpida, Pherecydes Pharma, Cempra, HandyLab, and Scynexis.

Where is Cocrystal Pharma headquartered?

Cocrystal Pharma is headquartered in United States.

How many employees does Cocrystal Pharma have?

Cocrystal Pharma has 1,000 employees 🔒.

When was Cocrystal Pharma founded?

Cocrystal Pharma was founded in 2010 🔒.

What sector and industry vertical is Cocrystal Pharma in?

Cocrystal Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Cocrystal Pharma

Who are the top strategic acquirers in Cocrystal Pharma's sector and industry

Top strategic M&A buyers and acquirers in Cocrystal Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Cocrystal Pharma?

Top strategic M&A buyers groups and sectors for Cocrystal Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Cocrystal Pharma's sector and industry vertical

Which are the top PE firms investing in Cocrystal Pharma's sector and industry vertical?

Top PE firms investing in Cocrystal Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Cocrystal Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Cocrystal Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Cocrystal Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Cocrystal Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Cocrystal Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Cocrystal Pharma?

The key public trading comparables and valuation benchmarks for Cocrystal Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Cocrystal Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Cocrystal Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Cocrystal Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Cocrystal Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Cocrystal Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Cocrystal Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Cocrystal Pharma